Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,022.95
(
0.80%
)
US TECH 100
25,479.60
(
1.33%
)
Dow Jones
48,463.72
(
-0.15%
)
Brent Oil
92.66
(
-2.94%
)
Bitcoin
74,910.48
(
0.95%
)
News Focus
News Focus
Post# of 111102
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

JBizzle703

Send PM Follow Ignore
Followers 11
Posts 400
Boards Moderated 0
Alias Born 06/11/2018

JBizzle703

Re: uvaphd post# 40435

Wednesday, 07/04/2018 7:45:52 PM

Wednesday, July 04, 2018 7:45:52 PM

Post# of 111102
UVAPHD, that is my understanding as well. The AmnioStem cells are going to be different, and I believe that is why they are submitting an investigational new drug application for using to treat radiation toxicity.

https://www.medicaldevice-network.com/news/creative-medical-technology-holdings-reveals-stem-cell-product-success/

I don't know if they will have to follow a similar process for all treatments derived from AmnioStem. Seem's like having the patents for the various treatments with AmnioStem, is the first step, which they have accomplished.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CELZ News
More CELZ News